Ping Yeh is a transformational technologist and an entrepreneurial leader. He is known for his role as a Board Member and ex-CIO of Vyant Bio, a NASDAQ-listed company created from StemoniX, which is revolutionizing drug discovery using human brain organoids and AI/ML technology. With a background in engineering and business management, Yeh has been involved in driving transformation in various industries. He co-founded StemoniX after surviving cancer, leveraging his expertise in nanotechnology, manufacturing, and software development to build a team focused on transforming drug discovery and testing. He played a pivotal role in guiding StemoniX's growth, recognition, and eventual merger with Cancer Genetics to form Vyant. Yeh continues to drive transformative technologies through his role as a board member at Vyant.